Lifecore Biomedical, Inc.
LFCR· Nasdaq
LFCRLifecore Biomedical, Inc.
Source filing unavailable
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Revenue | $81.57M | $70.17M |
| Net Income | $3.34M | $2.06M |
| EPS Diluted | $0.13 | $0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
